AptarGroup, a drug delivery, consumer product dispensing and active packaging solutions company, announced that its Activ-Film™ technology has been selected to protect against a new SARS rapid antigen test for Covid-19 diagnosis. The test was recently granted emergency use authorisation (EUA) by the US Food and Drug Administration (FDA).
Brazilian President Jair Bolsonaro has announced that the country will be seeking emergency use authorisation for an Israeli-developed nasal spray to fight Covid-19. Israel describes the EXO-CD24, developed by the Ichilov Medical Centre in Israel, as a miracle treatment.
NEOGEN Corporation, an international food safety company, has announced the launch of Early Warning Covid-19 testing for wastewater. The solution is a piloted, accurate, and consistent test that monitors the presence of the SARS-CoV-2 virus in sludge from wastewater facilities. NEOGEN’s test aims to deliver precise results that quickly detect new disease outbreaks and provide early signs of infections and spread within facilities.